These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25370818)

  • 1. Incorporation of a prolyl hydroxylase inhibitor into scaffolds: a strategy for stimulating vascularization.
    Sham A; Martinez EC; Beyer S; Trau DW; Raghunath M
    Tissue Eng Part A; 2015 Mar; 21(5-6):1106-15. PubMed ID: 25370818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M
    Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of dimethyloxallyl glycine in mesoporous bioactive glass scaffolds to improve angiogenesis and osteogenesis of human bone marrow stromal cells.
    Wu C; Zhou Y; Chang J; Xiao Y
    Acta Biomater; 2013 Nov; 9(11):9159-68. PubMed ID: 23811216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting.
    Lim SH; Kim C; Aref AR; Kamm RD; Raghunath M
    Integr Biol (Camb); 2013 Dec; 5(12):1474-84. PubMed ID: 24190477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-mimicking bioactive glass/collagen glycosaminoglycan composite scaffolds to enhance angiogenesis and bone repair.
    Quinlan E; Partap S; Azevedo MM; Jell G; Stevens MM; O'Brien FJ
    Biomaterials; 2015 Jun; 52():358-66. PubMed ID: 25818442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pro-angiogenic role of hypoxia inducible factor stabilizer FG-4592 and its application in an in vivo tissue engineering chamber model.
    Zhou M; Hou J; Li Y; Mou S; Wang Z; Horch RE; Sun J; Yuan Q
    Sci Rep; 2019 Apr; 9(1):6035. PubMed ID: 30988335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity.
    Liu X; Tu Y; Zhang L; Qi J; Ma T; Deng L
    Cell Biochem Biophys; 2014 May; 69(1):141-9. PubMed ID: 24242187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supercritical CO
    Li S; Song C; Yang S; Yu W; Zhang W; Zhang G; Xi Z; Lu E
    Acta Biomater; 2019 Aug; 94():253-267. PubMed ID: 31154054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralized poly(lactic acid) scaffolds loading vascular endothelial growth factor and the in vivo performance in rat subcutaneous model.
    Kim JH; Kim TH; Jin GZ; Park JH; Yun YR; Jang JH; Kim HW
    J Biomed Mater Res A; 2013 May; 101(5):1447-55. PubMed ID: 23114998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.
    Chen H; Jia P; Kang H; Zhang H; Liu Y; Yang P; Yan Y; Zuo G; Guo L; Jiang M; Qi J; Liu Y; Cui W; Santos HA; Deng L
    Adv Healthc Mater; 2016 Apr; 5(8):907-18. PubMed ID: 26891197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury.
    Zeng X; Zeng YS; Ma YH; Lu LY; Du BL; Zhang W; Li Y; Chan WY
    Cell Transplant; 2011; 20(11-12):1881-99. PubMed ID: 21396163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.
    Uchida L; Tanaka T; Saito H; Sugahara M; Wakashima T; Fukui K; Nangaku M
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F388-F401. PubMed ID: 31841388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bio-inspired hybrid nanosack for graft vascularization at the omentum.
    Hwang PT; Lim DJ; Fee T; Alexander GC; Tambralli A; Andukuri A; Tian L; Cui W; Berry J; Gilbert SR; Jun HW
    Acta Biomater; 2016 Sep; 41():224-34. PubMed ID: 27286678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.
    Ghadge SK; Messner M; Van Pham T; Doppelhammer M; Petry A; Görlach A; Husse B; Franz WM; Zaruba MM
    J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
    Jia P; Chen H; Kang H; Qi J; Zhao P; Jiang M; Guo L; Zhou Q; Qian ND; Zhou HB; Xu YJ; Fan Y; Deng LF
    J Biomed Mater Res A; 2016 Oct; 104(10):2515-27. PubMed ID: 27227768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung.
    Asikainen TM; Schneider BK; Waleh NS; Clyman RI; Ho WB; Flippin LA; Günzler V; White CW
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10212-7. PubMed ID: 16009933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis.
    Wang Y; Han X; Fu M; Wang J; Song Y; Liu Y; Zhang J; Zhou J; Ge J
    J Cell Mol Med; 2018 May; 22(5):2791-2803. PubMed ID: 29502357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics.
    Kular D; Macdougall IC
    Pediatr Nephrol; 2019 Mar; 34(3):365-378. PubMed ID: 29569190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of VEGF loading on scaffold-confined vascularization.
    Lindhorst D; Tavassol F; von See C; Schumann P; Laschke MW; Harder Y; Bormann KH; Essig H; Kokemüller H; Kampmann A; Voss A; Mülhaupt R; Menger MD; Gellrich NC; Rücker M
    J Biomed Mater Res A; 2010 Dec; 95(3):783-92. PubMed ID: 20725981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels.
    Janse van Rensburg A; Davies NH; Oosthuysen A; Chokoza C; Zilla P; Bezuidenhout D
    Acta Biomater; 2017 Feb; 49():89-100. PubMed ID: 27865963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.